Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The influence of glutamatergic receptor antagonists on biochemical and ultrastructural changes in myelin membranes of rats subjected to experimental autoimmune encephalomyelitis.
A cytoarchitecture-driven myelin model reveals area-specific signatures in human primary and secondary areas using ultra-high resolution in-vivo brain MRI.
A case of hereditary diffuse leukoencephalopathy with axonal spheroids caused by a de novo mutation in CSF1R masquerading as primary progressive multiple sclerosis.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Quantitative sensory and motor measures detect change over time and correlate with walking speed in individuals with multiple sclerosis.
Emerging stem cell therapies: treatment, safety, and biology.
Transplanted microvascular endothelial cells promote oligodendrocyte precursor cell survival in ischemic demyelinating lesions.
[Criteria of ineffectiveness of treatment with first-line therapy: how to use MRI results in decision making?]
[Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report].
Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis.
Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments.
Research Findings on Overactive Bladder.
TRPM4 mRNA expression levels in peripheral blood mononuclear cells from multiple sclerosis patients.
A pilot study on factors involved with work participation in the early stages of multiple sclerosis.
Is there an increased risk of hip fracture in multiple sclerosis? Analysis of the Nationwide Inpatient Sample.
Measures of aging with disability in U.S. secondary data sets: Results of a scoping review.
Evolution of diagnostic criteria for multiple sclerosis.
Mechanical energy expenditure of subject with multiple sclerosis engaged in daily activities: a case study.
Stress in Multiple Sclerosis: Review of New Developments and Future Directions.
Dual task cost of walking is related to fall risk in persons with multiple sclerosis.
Fatigue, Sleep Quality, and Disability in Relation to Quality of Life in Multiple Sclerosis.
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis.
Immunoglobulin GM allotypes in multiple sclerosis.
Comparing voice self-assessment with auditory perceptual analysis in patients with multiple sclerosis.
[New aspects in the therapy of multiple sclerosis and optic neuritis.]
Pages
« first
‹ previous
…
476
477
478
479
480
481
482
483
484
…
next ›
last »